The US has approved a drug which aims to eliminate peanut allergies in children aged four to 17.
The treatment, called AR101, will be sold under the brand name Palforzia.
The drug has been designed to gradually reduce sensitivity to peanuts by exposing patients to a highly-refined version of peanut flour over the course of several months.
Comments